Recordati

Recordati was incorporated in 1926 and has its headquarters based in Milan, Italy. The company operates primarily in three main business categories: Pharmaceuticals, where it is known for its prescription drugs addressing a range of therapeutic areas such as urology, cardiovascular, dermatology, and gastrointestinal diseases; Orphan drugs, which are developed specifically for the treatment of rare diseases; and Over-the-counter (OTC) drugs, which include non-prescription medications for common conditions. Among Recordati's most important brands are Zanidip (lercanidipine), used in cardiovascular treatments; Urorec (silodosin), designed for urological conditions; and Procto-Glyvenol for hemorrhoid relief, in addition to a variety of other branded pharmaceuticals and specialized therapeutics. Recordati's market reach is global, with a strong sales network across Europe, and an extended presence in various international markets such as the Middle East, North Africa, the United States, Russia, and selected countries in Asia and Latin America. (Powered by AI)